Mylan’s CEO, Heather Bresch, has been forced to defend the pricing of its EpiPen under sceptical questioning from US politicians. Bresch (pictured) was summoned to a hearing in front of the ...

Heather Bresch, CEO of pharmaceutical company Mylan, appeared before the US government’s House Oversight and Government Reform Committee two weeks ago. In a hearing over the price of her company ...

Viatris launches review, plans share buybacks. CEO outlines strategy for cost structure and remediation efforts.